latest news releases from the newsroom
``Epic of the American Frontier'' -- The Story of a British family in America
CLAREMONT, Calif, January 16, 2003 (PRIMEZONE) -- When King Charles I of England was convicted of treason and beheaded in the mid-17th century, one of his devoted followers, Nicholas, was forced to leave his ancestral manor, undertake a perilous sea journey, and start a new life in the New World. Thus begins the more than 300-year history and the enduring generations of a British family, the Worthingtons, in America, in George Worthington's new book "Epic of the American Frontier: Glimpses of 300 Years of American History Through the Eyes of One Family" (now available through 1stBooks Library).
Ego vs. Spirit in A. E. Hinton's Re-Release of Book `Confessions of Lifetimes in the Fountain of Choice'
CHICAGO, Jan. 16, 2003 (PRIMEZONE) -- "Confessions of Lifetimes in the Fountain of Choice" (now available through 1stBooks Library), by A. E. Hinton, divulges the accounts of one spirit's journeys in the flesh after making a deal with the Ominous Voice to receive the gift of choice. As the soul struggles to choose its natural path toward oneness, each story confesses the accounts of that lifetime; showing how and why one element is chosen oppose to the other. The accounts of each chapter take the soul closer to the direction of the element (ego or spirit) chosen.
Wolf Popper LLP
Wolf Popper Files Securities Class Action Against Tellium, Inc. -- TELM
NEW YORK, Jan. 16, 2003 (PRIMEZONE) -- Wolf Popper LLP has filed a securities lawsuit against Tellium, Inc. (Nasdaq:TELM) on behalf of persons who purchased Tellium common stock pursuant to the Company's Registration Statement and Prospectus for its initial public offering dated May 15, 2001, including those persons who purchased Tellium common stock in the open market during the period May 17, 2001 through January 31, 2002 (the "Class Period").
Food for the Body, Mind, and Spirit, New `Cookbook' for People on the Go
LITTLETON, Colo., Jan. 16, 2003 (PRIMEZONE) -- Inspiration, motivation, guidance, wisdom and humor are only a few of the ingredients that one needs to have for a healthy and hearty meal that satisfies the body, mind, soul and spirit. In his new, provocative and definitive self-help book titled "The Wise One's Diet" (now available through 1stBooks Library), up-and-coming author, The Stranger, provides readers a nourishing menu that will surely touch their hearts, energize their spirits and change their lives -- one meal at a time.
Lindex Announces Annual General Meeting Decisions
STOCKHOLM, Sweden, Jan. 16, 2003 (PRIMEZONE) -- The Annual General Meeting of AB Lindex on 16 January 2003 confirmed the Board of Directors' proposal to pay a dividend to the shareholders of SEK 6.00 per share. 21 January 2003 was confirmed as the record day for the right to receive dividend. The dividend will be remitted by VPC on 24 January 2003.
Harwood Feffer LLP
Wechsler Harwood LLP Announces Class Action Lawsuit Against Annuity and Life Re (Holdings), Ltd. -- ANR
NEW YORK, Jan. 16, 2003 (PRIMEZONE) -- Wechsler Harwood LLP today announced that a securities class action has been commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of Annuity and Life Re (Holdings), Ltd. (NYSE:ANR) between February 12, 2001 and November 19, 2002, inclusive (the "Class Period"). A copy of the complaint filed in this action is available from the Court, or can be viewed on Wechsler Harwood web site at: www.whesq.com
Galapagos Launches Gene Silencing Platform at Keystone Symposia
MECHELEN, Belgium, Jan. 16, 2003 (PRIMEZONE) -- Galapagos Genomics, the Belgian functional genomics company, today announced that it has launched its SilenceSelect(TM) gene silencing platform. With SilenceSelect, Galapagos complements its adenovirus based gene expression platform with a proprietary silencing technology that induces an effective and long-term suppression of human genes. The SilenceSelect collection contains adenoviruses with gene sequences that induce knock-down through an RNA interference mechanism. This collection, covering the 5,000 genes of highest interest to the pharmaceutical industry, can be analyzed in cellular assays in search for genes that modulate a specific disease phenotype.